Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr. Reddy's Laboratories informs about company updates
Date: 16-01-2019Dr. Reddy's Laboratories has informed that the audit of the company’s Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US FDA, has been completed on January 15, 2019. The company has been issued a Form 483 with 4 observations, which the company is addressing.
The above information is a part of company’s filings submitted to BSE.